The efficacy and safety of <i>Saccharomyces boulardii</i> in addition to antofloxacin-based bismuth quadruple therapy for <i>Helicobacter pylori</i> eradication: a single-center, prospective randomized-control study.
Journal Information
Full Title: Therap Adv Gastroenterol
Abbreviation: Therap Adv Gastroenterol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology & Hepatology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declare that there is no conflict of interest."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the National Natural Science Foundation of China [Grant No. 82100687], Science and Technology Project of Fujian Province [Grant No. 2018Y9116, 2020J05283], Sailing Project of Fujian Medical University [Grant No. 2019QH1283, 2019QH1286], School Management Project of Fujian University of Traditional Chinese Medicine [Grant No. XB2022143], Outstanding Youth Training Program of 900TH Hospital [Grant No. 2019Q03]."
"Trial registration number: ChiCTR2200056931."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025